Search

Author/Creator Nandy, Partha

2. Evaluating Potential QT Effects of JNJ‐54861911, a BACE Inhibitor in Single‐ and Multiple‐Ascending Dose Studies, and a Thorough QT Trial With Additional Retrospective Confirmation, Using Concentration‐QTc Analysis. (5th March 2018)

Authors:
Timmers, Maarten; Sinha, Vikash; Darpo, Borje; Smith, Brian; Brown, Randy; Xue, Hongqi; Ferber, Georg; Streffer, Johannes; Russu, Alberto; Tritsmans, Luc; Solanki, Bhavna; Bogert, Jennifer; Van Nueten, Luc; Salvadore, Giacomo; Nandy, Partha
Journal:
Journal of clinical pharmacology
Issue:
Volume 58:Number 7(2018)
Page Start:
952
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Influence of model-predicted rivaroxaban exposure and patient characteristics on efficacy and safety outcomes in patients with acute coronary syndrome. (July 2019)

Authors:
Zhang, Liping; Yan, Xiaoyu; Nandy, Partha; Willmann, Stefan; Fox, Keith A. A.; Berkowitz, Scott D.; Sharma, Amarnath; Hermanowski-Vosatka, Anne; Schmidt, Stephan; Weitz, Jeffrey I.; Garmann, Dirk; Peters, Gary
Journal:
Therapeutic advances in cardiovascular disease
Issue:
Volume 13(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. P1‐052: A SINGLE ASCENDING DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF THE ANTI‐PHOSPHO‐TAU ANTIBODY JNJ‐63733657 IN HEALTHY SUBJECTS. (1st July 2019)

Authors:
Galpern, Wendy R.; Mercken, Marc; Van Kolen, Kristof; Timmers, Maarten; Haeverans, Katrin; Janssens, Luc; Triana-Baltzer, Gallen; Kolb, Hartmuth C.; Jacobs, Tom; Nandy, Partha; Malia, Thomas; Sun, Hong; Van Nueten, Luc
Journal:
Alzheimer's & dementia
Issue:
Volume 15:Supplement 7S(2019)Part 5
Page Start:
P252
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Practical guidance for dosing and switching from paliperidone palmitate 1 monthly to 3 monthly formulation in schizophrenia. (2nd November 2015)

Authors:
Gopal, Srihari; Vermeulen, An; Nandy, Partha; Ravenstijn, Paulien; Nuamah, Isaac; Buron Vidal, José Antonio; Berwaerts, Joris; Savitz, Adam; Hough, David; Samtani, Mahesh N.
Journal:
Current medical research and opinion
Issue:
Volume 31:Number 11(2015:Nov.)
Page Start:
2043
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Prospective dose selection and acceleration of paliperidone palmitate 3‐month formulation development using a pharmacometric bridging strategy. (24th July 2016)

Authors:
Samtani, Mahesh N.; Nandy, Partha; Ravenstijn, Paulien; Remmerie, Bart; Vermeulen, An; Russu, Alberto; D'hoore, Peter; Baum, Ellen Z.; Savitz, Adam; Gopal, Srihari; Hough, David
Journal:
British journal of clinical pharmacology
Issue:
Volume 82:Number 5(2016:Nov.)
Page Start:
1364
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗